ReviewCureus2022
Ivosidenib for IDH1 Mutant Cholangiocarcinoma: A Narrative Review.
Vikram Sumbly et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ReviewCureus2022
Vikram Sumbly et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.